MAKENSEY DURRANT: Open Payments
NPI 1063029486 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,585 in 84 payments from 18 companies in 2025. Trend: 2023 $1,523 · 2024 $1,199 · 2025 $4,585
Food & beverage: $3,442Travel & lodging: $1,143
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 19 | $1,962 |
| Alexion Pharmaceuticals, Inc. | 6 | $528 |
| ABBVIE INC. | 10 | $492 |
| Axsome Therapeutics, Inc. | 4 | $280 |
| PFIZER INC. | 12 | $208 |
| Lundbeck LLC | 6 | $201 |
| Biogen, Inc. | 6 | $201 |
| EMD Serono, Inc. | 4 | $183 |
| Medtronic, Inc. | 4 | $159 |
| Otsuka America Pharmaceutical, Inc. | 1 | $99 |
Products named: INFINITY, ULTOMIRIS, Symbravo, QULIPTA, NURTEC ODT, VYEPTI, PROCLAIM, PERCEPT PC BRAINSENSE.
Industry payments across AZ — which companies pay providers there.
